Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
July 24, 2024
July 24, 2024
NEW BRUNSWICK, New Jersey, July 24 (TNSres) -- Johnson and Johnson issued the following news release:
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held at the New York Marriott Marquis, New York, NY.
Joaquin Duato, Chairman and Chief Executive Officer and John Reed, Executive Vice President, Innovative Medicine, R&D will represent the Company in a session scheduled at 1 . . .
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held at the New York Marriott Marquis, New York, NY.
Joaquin Duato, Chairman and Chief Executive Officer and John Reed, Executive Vice President, Innovative Medicine, R&D will represent the Company in a session scheduled at 1 . . .